For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221201:nRSA2890Ia&default-theme=true
RNS Number : 2890I Wellington Management Group LLP 01 December 2022
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing Wellington Management Group LLP
Company dealt in Sanofi
Class of relevant security to which the Ordinary shares (FR0000120578)
dealings being disclosed relate
Date of dealing 30 November 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security
dealt in
Long Short
Number (%) Number (%)
(1) Relevant securities 238,963 shares 0.02 % -21,195 shares 0.00 %
(2) Derivatives (other than options): -1,067 shares 0.00 %
(3) Options and agreements to purchase/sell: -12,076 shares 0.00 %
Total 238,963 shares 0.02 % -34,338 shares 0.00 %
(b) Interests and short positions in relevant securities of the company, other
than the
class dealt in
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options):
(3) Options and agreements to purchase/sell:
Total
3. DEALINGS
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(b) Derivatives transactions (other than options transactions)
Product name Nature of transaction Number of relevant securities Price per unit
e.g. CFD
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which the option relates Exercise price Type, e.g. American, European etc. Expiry date Option money paid/ received per unit
(ii) Exercising
Product name Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Nature of transaction Details Price per unit (if applicable)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 attached? YES
Date of disclosure 01 December 2022
Contact name Shaheen Hussain
Telephone number 44-20-7126-6099
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS
Product name, e.g. call option Written or purchased Number of relevant securities to which option or derivative relates Exercise price Type e.g. American, European etc. Expiry date
Equity Put Option Purchased 141 shares 58.0000USD American 16 Dec 22
Equity Put Option Purchased 141 shares 55.0000USD American 17 Mar 23
Equity Put Option Purchased 3,856 shares 61.0000USD American 20 Jan 23
Equity Put Option Purchased 3,856 shares 61.0000USD American 17 Feb 23
Equity Put Option Purchased 4,082 shares 53.0000USD American 30 Dec 22
Equity Swap Written 32 shares 15 May 23
Equity Swap Written 50 shares 15 May 23
Equity Swap Written 143 shares 05 May 23
Equity Swap Written 163 shares 15 May 23
Equity Swap Written 679 shares 15 May 23
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ISEMZMGZZMMGZZM